Francesco Imperi Selected Research

Francesco Imperi Research Topics

16	Infections 01/2022 - 01/2007
6	Starvation 01/2019 - 08/2005
5	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2007
5	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2014
1	Sepsis (Septicemia) 02/2021
1	Gram-Negative Bacterial Infections 01/2020
1	Neoplasms (Cancer) 05/2014
1	Dissociative Identity Disorder (Multiple Personalities) 05/2013
1	Cross Infection (Nosocomial Infection) 04/2011
1	Poisoning 01/2008
1	Persistent Infection 01/2007

8	IronIBA 01/2019 - 08/2005
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2014
5	Colistin (Coly-Mycin)FDA Link 01/2021 - 11/2012
4	pyoverdinIBA 01/2019 - 08/2005
3	GalliumIBA 01/2022 - 11/2012
3	Sigma FactorIBA 06/2010 - 08/2005
1	Fosfomycin FDA Link 02/2021
1	Chloramphenicol (Chloromycetin)FDA Link 02/2021
1	Vancomycin FDA LinkGeneric 02/2021
1	Lipid AIBA 05/2020
1	Biological ProductsIBA 11/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Phosphates (Orthophosphate)IBA 12/2017
1	phenylalanylarginineIBA 12/2017
1	Virulence Factors (Pathogenicity Factors)IBA 04/2017
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	gallium nitrate FDA Link 09/2015
1	Complement System Proteins (Complement)IBA 09/2015
1	Niclosamide FDA Link 08/2015
1	Chelating AgentsIBA 05/2013
1	Growth InhibitorsIBA 05/2013
1	Flucytosine (Ancobon)FDA Link 04/2013
1	LactonesIBA 04/2011
1	SulfurIBA 06/2010
1	Cyanides (Isocyanides)IBA 01/2008
1	Thiosulfate Sulfurtransferase (Rhodanese)IBA 01/2008

4	Therapeutics 01/2022 - 11/2012